Finance

Trade: Will Pfizer (PFE) beat quarterly earnings?

100% YES 0% NO

Opened 23 April 2026 · Settles 5 May 2026

Resolution criteria on PolyGram: As of market creation, Pfizer is estimated to release earnings on May 5, 2026. The Street consensus estimate for Pfizer’s non-GAAP EPS for the relevant quarter is $0.72 as of market creation. This market will resolve to "Yes" if Pfizer reports non-GAAP EPS greater than $0.72 for the relevant quarter in its next quarterly earnings release. Otherwise, it will resolve to "No." The resolution source will be the non-GAAP EPS listed in the company’s official earnings documents. If Pfizer releases earnings without non-GAAP EPS, then the market will resolve according to the non-GAAP EPS figure reported by SeekingAlpha.

PolyGram is an on-chain prediction market where you trade YES or NO outcome shares with real USDC on Polygon. For this market, buy YES if you believe the event will happen, or NO if you think it won't. Your maximum loss is your stake — winning shares pay $1.00 each at resolution. Unlike sportsbooks, there is no house edge: prices are set by supply and demand from other traders and reflect the crowd's real-time probability.

Liquidity: —
Total Volume: $3K
24h Volume: —
Open Interest: $3K

Trade this market on PolyGram →

Market outcomes

Will Pfizer (PFE) beat quarterly earnings?

100% YES

0% NO

Market context

Pfizer will announce first-quarter 2026 financial results on 5 May, with the market resolving based on whether non-GAAP earnings per share exceed the Street consensus estimate of $0.72. The current order book on Polymarket reflects a 100% implied probability of a beat, suggesting traders are pricing in minimal downside risk to earnings delivery at this stage.

Pfizer's recent earnings track record provides context for interpreting this extreme confidence. The company has beaten consensus EPS estimates in three of its last four quarterly releases, though margins have tightened amid competitive pressures in its core vaccine and oncology portfolios. Historical beats have typically ranged from 1–3 cents above consensus, with the company's guidance generally conservative enough to allow for modest upside surprises. However, the pharmaceutical sector remains sensitive to unexpected cost pressures, currency headwinds, and changes in demand for legacy products.

Key catalysts between now and the 5 May settlement include any material updates on Pfizer's pipeline progress, particularly regarding its RSV vaccine commercialisation and oncology expansions. Traders should monitor for announcements regarding manufacturing efficiency gains or cost restructuring initiatives that could influence margin assumptions embedded in current consensus estimates. Currency fluctuations will also matter, given Pfizer's substantial international revenue exposure. The current 100% probability on Polymarket's order book suggests the market is pricing in limited probability of an earnings miss, leaving room for repricing should forward guidance or pre-earnings commentary shift materially.

Wikipedia Context

Pfizer
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Founded in 1849 in New York by German entrepreneurs Charles Pfizer (1824–1906) and Charles F. Erhart (1821–1891), Pfizer is one of the oldest pharmaceutical companies in North America.
Penicillin
Penicillins are a group of β-lactam antibiotics originally obtained from Penicillium moulds, principally P. chrysogenum and P. rubens. Most penicillins in clinical use are synthesised by P. chrysogenum using deep tank fermentation and then purified. A number of natural penicillins have been discovered, but only two purified compounds are in clinical use: pen
Nirmatrelvir/ritonavir
Nirmatrelvir/ritonavir, sold under the brand name Paxlovid, is a co-packaged medication used as a treatment for COVID-19. It contains the antiviral medications nirmatrelvir and ritonavir and was developed by Pfizer. Nirmatrelvir inhibits SARS-CoV-2 main protease, while ritonavir is a strong CYP3A inhibitor, slowing down nirmatrelvir metabolism and therefore
Erythromycin
Erythromycin is an antibiotic used for the treatment of a number of bacterial infections. This includes respiratory tract infections, skin infections, chlamydia infections, pelvic inflammatory disease, and syphilis. It may also be used during pregnancy to prevent Group B streptococcal infection in the newborn, and to improve delayed stomach emptying. It can

Resolution source

This market settles from the official outcome published at https://seekingalpha.com/. A proposer submits the final result to the UMA optimistic oracle on Polygon; the two-hour dispute window closes and payouts clear in USDC.

How to trade this market step by step

The mechanics for trading "Will Pfizer (PFE) beat quarterly earnings?" are the same as any other PolyGram event contract. Each YES share resolves to $1 if the event happens, or $0 if it doesn't. The current price between 0¢ and 100¢ is the market's probability estimate, set live by the order book.

Sign in on polygram.ink with your email — no full KYC under $1,500 lifetime trading volume.
Deposit USDC on Polygon (lowest fees, ~$0.01 per transaction) or Ethereum. Funds credit after 12 confirmations.
Pick a side. Buy YES if you believe the event will happen; buy NO if you think it won't. The current YES price reflects the market's collective probability.
Size your position. If you stake 100 USDC at 100% YES, you'll receive shares that pay $100 if YES resolves true — a 0% gross return. If NO resolves, your shares are worth $0.
Set risk controls (optional). Stop-loss, take-profit, and limit-order types all supported. Use the trade ticket's slippage box to cap your maximum entry price.
Wait for resolution. When the event resolves on-chain via the UMA optimistic oracle, the winning side settles to 100¢ automatically and USDC hits your balance within seconds. Withdrawable to any wallet you control.

How active is this market?

$3K in lifetime turnover and $0 of resting liquidity puts this market in the below the median by volume for finance contracts on PolyGram. Order-book depth is thin — large orders may need to be split across the book or executed as limit orders.

The market has been open for under a month — fresh enough that information asymmetry remains a real factor.

Higher-volume markets tend to have tighter spreads and faster price discovery — meaning the displayed YES/NO percentages are more likely to reflect the true crowd-implied probability rather than a single trader's directional view.

Key terms

YES / NO share: A binary outcome token that pays $1.00 if the underlying claim resolves true (YES) or false (NO), and $0 otherwise. The market price between 0¢ and 100¢ is the implied probability.
CLOB: Central limit order book. The matching engine that pairs YES buyers with NO buyers (effectively the same trade). Polymarket's CLOB on Polygon executes trades on-chain via the conditional-tokens framework.
Liquidity: USDC capital sitting in resting limit orders inside the order book. Deeper liquidity means smaller slippage on large trades and a tighter bid-ask spread.
UMA optimistic oracle: The on-chain dispute system that settles each Polymarket market. A proposer submits the outcome, a two-hour challenge window opens, and unchallenged proposals finalise the resolution.
Slippage: The difference between the displayed mid-price and your fill price. Affects market orders most; limit orders avoid slippage but may take time to fill.
Conditional token: ERC-1155 outcome share issued by Gnosis Conditional Tokens on Polygon. The token type that resolves to $1.00 or $0.00 at settlement.

See the full prediction-market glossary →

Frequently asked questions

What is the current probability for "Will Pfizer (PFE) beat quarterly earnings?"?

As of today, traders on Polymarket price this outcome at 100%. The number updates continuously as the order book clears. PolyGram mirrors the same live odds with locale-aware formatting and USDC settlement.

How does this market resolve?

Resolution is sourced from https://seekingalpha.com/. Settlement is executed by the UMA optimistic oracle on Polygon, with a 2-hour dispute window before payouts clear.

When does this market close?

This prediction market is scheduled to close on 5 May 2026. After the resolving event occurs, settlement typically clears within 24 hours once the UMA optimistic oracle confirms the outcome. All payouts are in USDC on the Polygon network.

How can I trade on "Will Pfizer (PFE) beat quarterly earnings?"?

To trade on this prediction market, create a free PolyGram account at polygram.ink, deposit USDC via Polygon, and place a YES or NO order on the outcome you believe in. You can learn more on our how-it-works page. Your maximum loss is limited to your stake — there is no leverage or margin.

What happens when the market resolves?

When the outcome is determined, winning YES shares pay out $1.00 each in USDC, while losing shares pay $0. Settlement is handled by the UMA optimistic oracle on Polygon — a proposer submits the result, a two-hour dispute window opens, and if uncontested, payouts are distributed automatically. You can withdraw your winnings to any Polygon wallet.

Risk and regulatory note

Prediction-market positions can lose 100% of staked capital. Outcomes are uncertain by definition — historical accuracy of crowd-implied probabilities is high in aggregate but not for any single market. PolyGram does not provide investment advice. Trade only with capital you can afford to lose.

Regulatory status varies by jurisdiction. Germany, the United States, and most EU countries treat Polymarket-style event contracts under one of three frameworks: financial derivative, gambling product, or unregulated novel asset. Consult local counsel before trading.

View live odds & trade →

Related prediction markets

Explore more prediction market odds and trading opportunities on PolyGram: